Drug intelligence / Profile preview

wumei pill

Development stage
Preclinical
Lead developer
Eye Hospital, China Academy of Chinese Medical Sciences
Administration
Oral
01

Overview

Wumei pill (Wumei Wan) is a classic Traditional Chinese Medicine (TCM) formula first recorded in the *Shanghan Lun* (Treatise on Febrile Diseases) by Zhang Zhongjing. It is the primary prescription for treating "Jueyin" syndrome, which is characterized by a complex mixture of cold and heat. Historically, it was indicated for intestinal parasitosis (calming roundworms) and chronic diarrhea. The formula typically consists of ten botanical and mineral ingredients: Mume Fructus (Wumei), Asari Radix et Rhizoma (Xixin), Zingiberis Rhizoma (Ganjiang), Coptidis Rhizoma (Huanglian), Angelicae Sinensis Radix (Danggui), Aconiti Lateralis Radix Praeparata (Fuzi), Zanthoxyli Pericarpium (Shujiao), Cinnamomi Ramulus (Guizhi), Ginseng Radix et Rhizoma (Renshen), and Phellodendri Chinensis Cortex (Huangbai). In modern clinical research, particularly at the Eye Hospital of the Chinese Academy of Chinese Medical Sciences, it is being investigated for its potential to lower intraocular pressure and protect visual function in patients with primary open-angle glaucoma by regulating biological rhythms and addressing the pathological damage associated with Jueyin disease.

Other names
Wumei WanMume Pill
02

Targets

RELA (Nuclear Factor Kappa B Subunit p65)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)

Beyond the preview

Go deeper on wumei pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on wumei pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call